Google+ Badge

Thursday, July 30, 2015

Cardiovascular Research:Can we restart the heart? ♦ Some stroke treatments proven to reduce healthcare costs ♦ Blood pressure reduction role of commonly prescribed drug

One in four patients with defibrillators experiences boost in heart function over time A study of outcomes among 1,200 people with implanted defibrillators — devices intended to prevent sudden cardiac death from abnormal heart rhythms — shows that within a few years of implantation, one in four experienced improvements in heart function substantial enough to put them over the clinical threshold that qualified them to get a defibrillator in the first place.
Some stroke treatments proven to reduce healthcare costs Use of mechanical thrombectomy on qualifying stroke patients could result in major savings to the healthcare economy in the United Kingdom and other western countries with a similar healthcare structure.
Can we restart the heart? What if you could use the proliferative and survival properties of cancer-prone cells to rejuvenate cardiac progenitor cells and get them dividing again, without forming tumors? Researchers are exploring the results of taking an enzyme, Pim, known to be associated with growth and survival of certain types of cancer cells, and causing it to be overexpressed in cardiac progenitor cells in mice.
Blood pressure reduction role of commonly prescribed drug A drug commonly prescribed to conserve potassium in the blood also significantly lowers blood pressure when taken in conjunction with a diuretic frequently prescribed to patients with hypertension, a new big data study has found. The combination of the two drugs, both available as generics, has been shown to consistently amplify the blood pressure reduction in patients with or without the presence of other antihypertensive agents such as ACE inhibitors and calcium channel blockers.

No comments:

Post a Comment